- Home
- DMRA vs QNT Comparison
DMRA vs QNT Comparison
Compare DMRA & QNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DMRA | QNT |
|---|---|---|
| Founded | 2011 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2020 | 2026 |
Fundamental Metrics
Financial Performance| Metric | DMRA | QNT |
|---|---|---|
| Price | $21.33 | $37.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 13 |
| Target Price | $46.89 | ★ $95.83 |
| AVG Volume (30 Days) | 425.0K | ★ 2.0M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 121.48 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $102.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.50 | $33.02 |
| 52 Week High | $34.89 | $86.79 |
Technical Indicators
Market Signals| Indicator | DMRA | QNT |
|---|---|---|
| Relative Strength Index (RSI) | 48.77 | 41.44 |
| Support Level | $17.69 | $33.02 |
| Resistance Level | $21.86 | $53.25 |
| Average True Range (ATR) | 1.35 | 2.68 |
| MACD | 0.51 | 0.20 |
| Stochastic Oscillator | 71.75 | 43.54 |
Price Performance
Historical ComparisonAbout DMRA Damora Therapeutics Inc. Common Stock
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
About QNT Quantinuum Inc. Class A Common Stock
Quantinuum Inc. is providing a full-stack quantum technology solution to scale quantum computing and develop applications. Its products and solutions are Quantinuum Systems, Helios, Quantum Origin, InQuanto, Nexus, and Developer Tools.